Evidence map›Paper›PMID 35492810›Full record

ArticleJACC. CardioOncology2022

Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors.

Kerryn W Reding, Richard K Cheng, Alexi Vasbinder, Roberta M Ray, Ana Barac, Charles B Eaton, Nazmus Saquib, Aladdin H Shadyab, Michael S Simon, Dale Langford and 3 more

Open access · goldAbstract read
In one paragraph

Article in JACC. CardioOncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Cancer and Heart Failure: Dangerous Liaisons.Journal of cardiovascular development and disease · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 2 countries.

Kerryn W RedingBiobehavioral Nursing and Health Informatics Department, University of Washington School of Nursing, Seattle, Washington, USA.
Richard K ChengDepartment of Cardiology, University of Washington School of Medicine, Seattle, Washington, USA.
Alexi VasbinderBiobehavioral Nursing and Health Informatics Department, University of Washington School of Nursing, Seattle, Washington, USA.
Roberta M RayPublic Health Sciences Division, Fred Hutch Cancer Research Center, Seattle, Washington, USA.
Ana BaracMedStar Health Heart and Vascular Institute, Baltimore, Maryland, USA.
Charles B EatonCenter for Primary Care and Prevention, Alpert School of Medicine, Brown University, Providence, Rhode Island, USA.
Nazmus SaquibSulaiman AlRajhi University, Al Qassim, Saudi Arabia.
Aladdin H ShadyabHerbert Wertheim School of Public Health and Human Longevity Science, University of California-San Diego, San Diego, California, USA.
Michael S SimonDivision of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
Dale LangfordDepartment of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Mary BranchDepartment of Cardiology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Bette CaanDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Garnet AndersonPublic Health Sciences Division, Fred Hutch Cancer Research Center, Seattle, Washington, USA.
University of Washington · USFred Hutch Cancer Center · USBrown University · USGeorgetown University · USKaiser Permanente · USSulaiman Al Rajhi Colleges · SAUniversity of California San Diego · USWake Forest University · USWayne State University · US

Funding

Women's Health Initiative Cancer Survivor CohortUM1CA173642 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ANDERSON, GARNET L., CAAN, BETTE J · 2013 to 2018
$12.1M
Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor CohortU01CA173642 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ANDERSON, GARNET L., PASKETT, ELECTRA D. · 2019 to 2023
$7.5M
Biomarkers of Long-Term Fatigue in Breast Cancer Survivors Treated with RadiationF31NR018588 · NINR · UNIVERSITY OF WASHINGTON · PI VASBINDER, ALEXI L · 2019 to 2020
$89k
NCI NIH HHS U01 CA173642NCI NIH HHS UM1 CA173642NINR NIH HHS F31 NR018588
6 · The paper itself

Abstract

Background: Breast cancer (BC) survivors experience an increased burden of long-term comorbidities, including heart failure (HF). However, there is limited understanding of the risk for the development of HF subtypes, such as HF with preserved ejection fraction (HFpEF), in BC survivors. Objectives: This study sought to estimate the incidence of HFpEF and HF with reduced ejection fraction (HFrEF) in postmenopausal BC survivors and to identify lifestyle and cardiovascular risk factors associated with HF subtypes. Methods: Within the Women's Health Initiative, participants with an adjudicated diagnosis of invasive BC were followed to determine the incidence of hospitalized HF, for which adjudication procedures determined left ventricular ejection fraction. We calculated cumulative incidences of HF, HFpEF, and HFrEF. We estimated HRs for risk factors in relation to HF, HFpEF, and HFrEF using Cox proportional hazards survival models. Results: In 2,272 BC survivors (28.6% Black and 64.9% White), the cumulative incidences of hospitalized HFpEF and HFrEF were 6.68% and 3.96%, respectively, over a median of 7.2 years (IQR: 3.6-12.3 years). For HFpEF, prior myocardial infarction (HR: 2.83; 95% CI: 1.28-6.28), greater waist circumference (HR: 1.99; 95% CI: 1.14-3.49), and smoking history (HR: 1.65; 95% CI: 1.01-2.67) were the strongest risk factors in multivariable models. With the exception of waist circumference, similar patterns were observed for HFrEF, although none were significant. In relation to those without HF, the risk of overall mortality in BC survivors with hospitalized HFpEF was 5.65 (95% CI: 4.11-7.76), and in those with hospitalized HFrEF, it was 3.77 (95% CI: 2.51-5.66). Conclusions: In this population of older, racially diverse BC survivors, the incidence of HFpEF, as defined by HF hospitalizations, was higher than HFrEF. HF was also associated with an increased mortality risk. Risk factors for HF were largely similar to the general population with the exception of prior myocardial infarction for HFpEF. Notably, both waist circumference and smoking represent potentially modifiable factors.

Indexed as

BC, breast cancerBMI, body mass indexbreast cancercancer survivorshipcardio-oncologyCVD, cardiovascular diseaseER, estrogen receptorheart failureHF, heart failureHFpEF, heart failure with preserved ejection fractionHFrEF, heart failure with reduced ejection fractionLVEF, left ventricular ejection fractionMI, myocardial infarctionobesityPR, progesterone receptorWHI, Women’s Health Initiative

Identifiers

PMID35492810
PMCPMC9040098
OpenAlexW4220777147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.